Mouse model develops Parkinsons just like humans, opening the door to more...
LA JOLLA, CA – To study a disease, scientists need to be able to track its progression in a living organism, such as a mouse. But scientists studying Parkinson’s disease have found it challenging to...
View ArticleMolecules that prevent protein misfolding point to new type of therapy for AL...
Scripps Research team finds promising molecules for stabilizing abnormal proteins that cause disease.read more
View ArticleMolecules that curb errant proteins of AL amyloidosis point to new type of...
Scripps Research team finds promising molecules for stabilizing abnormal proteins that cause disease.read more
View ArticleNew study suggests oxytocin could help treat alcohol addiction
Scripps Research team, working with NIH’s National Institute on Drug Abuse, discover a promising approach for pharmaceutical interventions to decrease excessive drinking.read more
View ArticleSydney Brenner, Nobel laureate and genetics pioneer, dies at 92
Sydney Brenner, PhD, a pioneer in genetics, molecular biology and neuroscience who collaborated closely with Scripps Research scientists, died April 5 at the age of 92.read more
View ArticleChemist Jin-Quan Yu of Scripps Research elected to American Academy of Arts...
LA JOLLA, CA – The American Academy of Arts and Sciences, one of the world’s most prestigious honor societies, has named Scripps Research chemist Jin-Quan Yu, PhD, as an elected member of its 2019...
View ArticleNew POWERMOM app launched to study maternal health
LA JOLLA, CA – In the United States, spending on hospital-based maternity care surpasses that of any other country, yet rates of maternal morbidity and mortality are rising, despite declines...
View ArticleGene repair improves memory and seizures in adult autism model
JUPITER, FL – A new study challenges the presumption that people born with developmental brain disorders such as severe autism will benefit from medical interventions only if treated during a narrow...
View ArticleVaccine shows lasting effects against deadly synthetic opioids
LA JOLLA, CA – Scientists at Scripps Research have developed an experimental vaccine that may one day help treat addiction to fentanyl, a highly potent opioid linked to an epidemic of overdoses and...
View ArticleScripps Research selects high school summer interns for 15th annual Kenan...
Nine-week program to include laboratory skills ‘boot camp’ and conclude with celebration reuniting former participants from as far back as 2005.read more
View ArticleFDA approves Scripps Research-originated drug tafamidis for cardiomyopathy
LA JOLLA, CA – The U.S. Food and Drug Administration has approved tafamidis, a medicine invented by Scripps Research professors Jeffery Kelly, PhD, and Evan Powers, PhD, for the treatment of heart...
View ArticleScripps Research spin-off Abide Therapeutics to be acquired by Danish pharma...
Abide Therapeutics Inc., a clinical-stage biopharmaceutical company founded by Scripps Research professors Benjamin Cravatt, PhD, and Dale Boger, PhD, will be acquired by the Danish pharmaceutical firm...
View ArticleChemical biologist Benjamin Cravatt of Scripps Research wins prestigious...
LA JOLLA, CA – Benjamin Cravatt, PhD, the Gilula Chair of Chemical Biology at Scripps Research, has been named winner of the prestigious Jeremy Knowles Award from the Royal Society of Chemistry.read more
View ArticleChemist Keary Engle receives Dreyfus Foundation Teacher-Scholar Award
The Camille and Henry Dreyfus Foundation, a leading nonprofit organization dedicated to advancing chemical sciences, has selected Scripps Research faculty member Keary Engle, PhD, for the 2019 Camille...
View ArticleNanotubes enable travel of Huntingtons disease protein
Jupiter, FL - A toxic protein linked to Huntington’s disease can move from neuron to neuron through a nanotube tunnel whose construction is initiated by a protein called Rhes, say scientists at Scripps...
View ArticleFDA approves phase 1/2 clinical trial with ABX196 in patients with liver cancer
ABX196 to be tested in combination with checkpoint inhibitor nivolumab to treat hepatocellular carcinoma.read more
View ArticleScripps Research awards doctorates to largest graduating class in institutes...
LA JOLLA, CA — Scripps Research’s Skaggs Graduate School of Chemical and Biological Sciences will recognize the outstanding research accomplishments of more than 50 graduate students, comprising the...
View ArticleScripps Research ranked second in the world among scientific institutes for...
LA JOLLA, CA – Nature Index has ranked Scripps Research second in the world and first in the United States among stand-alone scientific institutes for biomedical research, based on discoveries by the...
View ArticleForget what the textbooks say, human natural killer cells do remember past...
LA JOLLA, CA – Scientists at Scripps Research have discovered that the immune system’s “natural killer” (NK) cells have a hidden talent. Long thought to be short-lived, indiscriminate attackers of...
View ArticleMonkey-infecting virus may provide part of future HIV vaccine
LA JOLLA, CA – A protein from Simian Immunodeficiency Virus (SIV), which can infect monkeys and apes, has shown promise as a potential component of a vaccine against Human Immunodeficiency Virus (HIV),...
View Article